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Ageing is a complex process that in muscle is usually associated with a decrease in mass, strength, and velocity of contraction.
One of the most striking eﬀects of ageing on muscle is known as sarcopenia. This inevitable biological process is characterized by
a general decline in the physiological and biochemical functions of the major systems. At the cellular level, aging is caused by a
progressive decline in mitochondrial function that results in the accumulation of reactive oxygen species (ROS) generated by the
addition of a single electron to the oxygen molecule. The aging process is characterized by an imbalance between an increase in the
productionofreactiveoxygenspeciesintheorganismandtheantioxidantdefencesasawhole.Thegoalofthisreviewistoexamine
theresultsofexistingstudiesonoxidativestressinaginghumanskeletalmuscles,takingintoaccountdiﬀerentphysiologicalfactors
(sex, ﬁbre composition, muscle type, and function).
1.H umanA gingM usc le:A nOv e rvie w
Aging represents an inevitable and complex biological pro-
cessthatischaracterizedbyageneraltime-dependentdecline
in the physiological and biochemical functions of the major
systems [1]. Several changes can be observed during aging,
which include a reduced capacity to use oxygen along with
impaired cardiocirculatory capacity and respiratory adapta-
tion, deterioration of nervous system (decrease in the form,
width, and rate of conduction of evoked potential), and
degeneration in muscle mass characterized by a reduction in
muscle ﬁber diameters and by a qualitative and quantitative
alteration in muscle ﬁbres [2].
Also at the cellular level, morphological and biochemical
changes are involved in this process. Skeletal muscle can be
considered the largest organ in the body [3] and the age-
associated loss of skeletal muscle mass and strength (i.e.,
sarcopenia) seems an unavoidable part of the aging process.
After about the age of 50 years, there is a progressive decrease
of muscle mass at the rate of 1-2% per year. Similarly
b u tw i t hd i ﬀerent decline rate and timing, muscle strength
also decreases by about 3% yearly after 60 years of age [4]
while the cross-sectional area of skeletal muscle is reduced
by 25–30% after age 70 [4–6]. Sarcopenia is, therefore, a
multidimensional phenomenon of aging (someone indicates
itasasyndrome)andrepresentsapowerfulriskfactorforthe
development of negative health-related events in the elderly.
Infact,therelationshipsofsarcopeniawithimpairedphysical
performance, frailty, loss of functional independence, and
increased risk of falls are all well established in literature
[7]. Moreover, decreased muscle strength is also highly
predictive of incident disability, and all-cause mortality in
older persons [8]. An important aspect regards the diﬀerent
functional decline associated with sarcopenia, which is more
evident in men than in women [9]. Moreover, the extent
of sarcopenia, and thus age-related atrophy, are higher in
glycolytic muscles compared to oxidative muscles [10, 11];
Type I ﬁbers are slow contracting, mainly oxidative, while
type II ﬁbres are fast contracting, mainly glycolytic with a
lower number of mitochondria. In humans, the structural
changes of responsible for age-related atrophy and decline in
muscle strength are correlated to the progressive impairment
of the cross-sectional ﬁbre area [12] and to ﬁbre denervation
and ﬁbre number loss, with type II ﬁbres being the most2 Oxidative Medicine and Cellular Longevity
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Figure 1: mitochondria ROS production by [28].
aﬀected by aging [13, 14]. The remaining type II ﬁbres
seemstomaintaintheireﬃciencyprobablybyadjustingtheir
capability to produce energy, as suggested by the absence
of age-related changes in the enzymatic activities of the
anaerobic machinery for energy production [15–17].
One of the most important endogenous causes of
sarcopenia is likely correlated to the loss of a motor neuron
input to the muscle [18]. This decline of muscle innervation
may be one of the key events in the sarcopenic process since
innervation is crucial to the maintenance of muscle mass, as
well as strength. In the elderly, there is a decrease in the num-
ber of functional motor units associated with a concomitant
enlargement of the cross-sectional area of the remaining
units [19]. Together with neurological factors, a decline in
anabolic hormones may also play a key role in the sarcopenic
process. This reduction of anabolic hormones, namely,
growth hormone (GH) and sexual steroid hormones, could
be implicated in the aetiopathogenesys of the sarcopenic
process. Many studies have demonstrated that GH levels
begin to decline in the fourth decade and progressively
continue to decline over ensuing years. Interestingly, it seems
that sex hormones are an important factor in maintaining
muscle mass and strength in men but not in women [20–23].
Regarding the multifactorial aetiology in recent years many
assumptions were made about the causes of Sarcopenia that
can be very schematically summarized as follows [24].
(a) Mitochondrial deletion: a failure of replication of
mitochondrial DNA (mtDNA) may be the cause of a
signiﬁcantdeletioninthemitochondrialgenome;the
shorter genome is replicated more quickly by induc-
ing the formation of malfunctioning or completely
inactive mitochondria.
(b) Alteration of protein synthesis.
(c) Loss of the ability of reparative satellites cells (SC):
the proliferation and fusion of the SC is regulated by
speciﬁcgrowthfactorsprotein(mainlyIGF-1,mIGF-
1, HGF) but is also inﬂuenced by hormones such as
GH, testosterone, and estrogen. Moreover, satellite
cells are also activated by mechanical stretch, and
muscle or sarcolemmal damage. One of the factors
that could play a key role in triggering sarcopenia is
the accumulation of reactive oxygen species (ROS)
that have produced throughout one’s lifetime [2].
ROS, which are generated by the addition of a single
electron to the oxygen molecule, are formed in all
tissues including muscle ﬁbers and, especially, in the
mitochondrial respiratory chain.
2. Mitochondrial ROS Production,mtDNA
Mainteinance,andSkeletalMuscleAging
The generation of reactive oxygen species (ROS) and reactive
nitrogen species (RNS) is a normal process in the life of
aerobic organism; ROS and RNS, in fact, are continually
produced as a consequence of aerobic metabolism: up to 5%
of oxygen reacting with the respiratory chain is incompletely
reduced to ROS [15, 25, 26]. This production contributes
to mitochondrial damage in a range of pathologies and is
also important in redox signalling from the organelles to the
rest of the cell. A schematic overview of the mitochondrial
ROSproductionisshownintheFigure 1:R OSproductionby
mitochondria can lead to oxidative damage to mitochondrial
proteins, membranes, and DNA, impairing the ability of
mitochondria to synthesize ATP and to carry out their wide
range of metabolic functions, including the tricarboxylic
acid cycle, fatty acid oxidation, the urea cycle, amino acidOxidative Medicine and Cellular Longevity 3
metabolism, haem synthesis, and FeS centre assem bly that
are central to the normal operation of most cells. Mito-
chondrial oxidative damage can also increase the tendency of
mitochondria to release intermembrane space proteins such
as cytochrome c (cyt c) to the cytosol by mitochondrial outer
membrane permeabilization (MOMP) and consequently
activate the cell’s apoptotic machinery. It is well established
that apoptosis is elevated during aging of cells and tissues
and signiﬁcantly contributes to cell loss and the pathogenesis
of several age-related diseases [27]. In fact, mitochondrial
ROS production also leads to induction of the mitochondrial
permeability transition pore (PTP), which renders the inner
membrane permeable to small molecules in situations such
as ischaemia/reperfusion injury. Consequently, it is unsur-
prising that mitochondrial oxidative damage contributes to
a wide range of pathologies. Moreover, mitochondrial ROS
mayactasamoduletableredoxsignal,reversiblyaﬀectingthe
activity of a range of functions in the mitochondria, cytosol,
and nucleus [28].
ROS include oxygen free radical, the superoxide radical
anion (O2
•−, primary product of one-electron dioxygen
reduction, precursor of most other reactive oxygen species
and involved in the propagation of oxidative chain reactions,
even though it is not a strong oxidant), the extremely aggres-
sive hydroxyl radical (deriving from subsequent chemical
reaction), and the strong nonradical oxidants, singlet oxygen
and hydrogen peroxide [15]:
O2+1e
−−→ O2+1e
−−→ H2O2+1e
−−→ HO+1e
−−→ H2O
(1)
ROS-mediated damage is the result of an increase in electron
ﬂux and the corresponding leakage from the mitochondrial
respiratory chain [15].
Inmuscleﬁbres,ROS,inparticularthesuperoxideanion,
can be produced in several cellular sites, including plasma
membrane, mitochondria, sarcoplasmic reticulum (SR), T
tubules, sarcolemma and cytosol, and they are generally
released in the cytosol of the cell muscle [29].
The skeletal muscle is the largest consumer of oxygen
in the body, and in the literature, there are several debates
about the relationship between the aging in this tissue and
the changes of the cellular antioxidant defence mechanism
with a progressive ROS increase [30]. Oxidative damage
has been proposed as one of the major contributors of the
skeletal muscle decline occurring with aging [31, 32]. In
general, this lack of results homogeneity in literature could
be related to the variety of mechanisms that can lead to
free radical production and that can be modulated by aging,
sex, ﬁbre composition, muscle type, and the physiological
state of the animals [15]. Summarizing the ﬁndings of the
last years, if oxidative stress plays an important role in
the aging of skeletal muscle, in particular of the satellite
cells, that are usually recruited to replace damaged ﬁbers
and promote their regeneration, the susceptibility against
oxidative stress seems to be less prominent in this kind of
cells with respect to other cell systems, since oxidative stress
is counteracted by an increase in the antioxidant defence
system [20]. Cellular antioxidant defence, in fact, has been
shown to play an interesting role in advanced age: in the
liver,brain,heart,kidney,andratskeletalmuscleagingseems
to be associated with reduced capacity of enzymatic and
nonenzymatic antioxidant system to convert ROS into more
inert species [33, 34]. The redox imbalance is this disparity
between ROS generation and the counter-acting antioxidant
forces, and it constitutes the major trigger of the imbalance
between protein synthesis and degradation that in turn leads
to muscle atrophy [35, 36]. How such an oxidative insult
playsaroleintheage-relateddecreaseofmuscleperformance
and mass has yet to be deﬁned. In aged muscle, there is
an increase in the presence of the products of oxidative
damage to lipids, proteins, and DNA [37] together with a
marked increase in the number and variety of mitochondrial
DNA rearrangements [38]. On the other hand, a causal rela-
tionship between oxidative macromolecules modiﬁcations,
mitochondrial DNA mutations, mitochondrial dysfunction
and aging is now clearly demonstrable [39]. The increased
ROS production in mitochondria, hence, can subsequently
lead to a vicious cycle of exponentially increasing levels of
mtDNA damage.
T h el a c ko fp r o t e c t i v eh i s t o n e sa n dc l o s ep r o x i m i t yt o
the ETC, whose complexes I and III are believed to be
the predominant sites of ROS production inside the cell,
make mtDNA extremely vulnerable to oxidative stress [38].
Although various genetic problems in mitochondria cause
phenotypes that resemble premature aging [40], additional
support for this theory was provided by studies showing
a direct link between mtDNA mutations and mammalian
aging. In particular, mice with a proofreading-deﬁcient
version of PolgA, the catalytic subunit of mitochondrial
DNA polymerase γ (POLG), accumulate mtDNA mutations
that are associated with impaired respiratory-chain function
and increased levels of apoptosis. These mtDNA-mutator
mice, with accelerated levels of mutations, had a shorter
life span and displayed age-related phenotypes such as hair
loss, kyphosis (curvature of the spine), osteoporosis, and
sarcopenia at an early age [40]. Interestingly, these changes
were not accompanied by increased levels of oxidative
stress, a ﬁnding that has also been conﬁrmed in humans
[41]. This has resulted in much controversy regarding the
idea that mtDNA mutations contribute to aging through
increased ROS production and enhanced levels of oxidative
stress in mitochondria [42]. However, it is possible that
the accumulation of mtDNA mutations that occur with
age leads to alterations in cell-signaling pathways that can
induce cell dysfunction and initiate apoptosis, irrespective
of increased ROS production and oxidative stress in mito-
chondria. Previous studies have provided strong, though
correlative, experimental support for an association between
mtDNA mutations and tissue dysfunction, particularly in
long-lived postmitotic cells such as cardiomyocytes, skeletal
muscle ﬁbers, and neurons. Moreover, mtDNA mutations
have been shown to accumulate with aging in several tissues,
including skeletal muscle of various species. Therefore, it
has been established that many of these mtDNA mutations
start to occur after the mid-thirties and they accumulate
with age in postmitotic tissues of the human body [43–
45]. Beside this, it was observed that the extent of mtDNA4 Oxidative Medicine and Cellular Longevity
mutation strongly correlates with the progressive decrease of
cytochrome c oxidase activity in aging human muscle [46].
Actually, whether mtDNA mutations play a causal role in
the aging process is still an ongoing debate; however, the
fact that a functional decline in mitochondria occurs with
age and that properly functioning mitochondria are crucial
for longevity and minimizing age-related diseases cannot be
refuted [42]. Another important aspect to be considered is
the motility of mitochondria which continuously undergo
fusion and ﬁssion events that actively alter their morphology
[43]. Therefore, genetic defects in the proteins involved in
mitochondrial fusion and ﬁssion lead to severely altered
mitochondrial shape, loss of mtDNA integrity, increased
oxidative stress, and apoptotic cell death; it has been shown
that these alterations can subsequently cause developmental
abnormality, neuromuscular degeneration, and metabolic
disorders in humans [44]. On the other hand there are
onlyfewin-depthstudyconﬁrmingthisrelationshipbetween
the mitochondrial fusion and ﬁssion mechanism and aging,
mostly because the molecular events that underlie the aging
process have not yet been completely elucidated. But an
important example that supports this concept is provided
by recent studies of mitochondria in muscle [42]. The
subcellular localization of mitochondria and the overall
mitochondrial network in multinucleated muscle ﬁbers are
tightly controlled by mitochondrion-shaping proteins, and
an imbalance in mitochondrial fusion and ﬁssion dynamics
probably impairs their function and contributes to the age-
related loss of muscle. Indeed, it has recently been shown
that the expression of two genes codifying for proteins
involved in mitochondrial fusion (Mfn1 and Mfn2)i s
reduced in the skeletal muscle of aging individuals [45].
Furthermore, the role of mitochondrion-shaping proteins
has recently been investigated in mice with a muscle-
speciﬁc deﬁciency in genes codifying for two key protein
(Fis1 and Drp1) of the regulation of mitochondrial ﬁssion
in mammalian cells: diminished mitochondrial ﬁssion was
associated with reduced muscle atrophy and attenuated
activationofatrophy-relatedgenesduringfasting[47].Inter-
estingly, the level of PGC-1α, a transcriptional coactivator
that enhances the activity of speciﬁc transcription factors
and that consequently stimulates the expression of Mfn2,
is decreased in various models of muscle atrophy [48–50],
whereas overexpression of PGC-1α protects skeletal muscle
from atrophy, mainly by inhibiting the induction of genes
that are crucial for the atrophy process [51, 52]. Many other
studies indicate that alterations in mitochondrial dynamics
are a key component of the mitochondrial adaptations
that occur in response to mitochondrial biogenesis. These
mitochondrial adaptations seem to be driven by regulatory
pathways that can be activated by several physiological
stimuli, including exercise and calorie restriction. However,
these studies are not suﬃcient to reveal the functional rela-
tionship between mitochondrial dynamics and biogenesis,
or to explain how fusion and ﬁssion events contribute to
mitochondrial turnover [42]. Nevertheless, as the results
of several studies on mammalian cells showed, there is a
relationship between mitochondrial dynamics and genomic
stability [50, 51]. Furthermore, following conﬁrmation of
the role of some genes like Mfn1 and Mfn2 in mtDNA
maintenance, loss of mitochondrial fusion in skeletal muscle
resulted in increased mtDNA point mutations and deletions
as well as severe mtDNA depletion, which preceded the
phenotypic changes observed in mice mutated for the genes
above mentioned (Mfn1 and Mfn2)[ 53–55]. These studies
support the hypothesis that mitochondrial fusion through
intramitochondrial exchange increases the tolerance of a
cell to mutant mtDNA and protects the integrity of the
mitochondrial genome [42].
In general, several lines of evidence indirectly implicate
mtDNA in longevity. The Framingham Longevity Study of
Coronary Heart Disease has indicated that longevity is more
strongly associated with age of maternal death than that of
paternal death, suggesting that mtDNA inheritance might be
involved [56]. On the other hand, longevity was shown to be
associated with certain mtDNA polymorphisms, which also
may play a role in aging process [57]. In the opinion of Alex-
eyef, the mitochondrial theory of aging can be considered
as an extension and reﬁnement of the free radical theory.
Its major premise is that mtDNA mutations accumulate
progressively during life and are directly responsible for a
measurable deﬁciency in cellular oxidative phosphorylation
activity, leading to an enhanced ROS production. In turn,
increased ROS production results in an increased rate of
mtDNA damage and mutagenesis, thus causing a “vicious
cycle” of exponentially increasing oxidative damage and
dysfunction, which ultimately culminates in death [58].
Regardingthegenetic modiﬁcations induced byROSand
various other oxidants, it was also found that radicals induce
M n S O Dm R N Al e v e l st oam o d e r a t ee x t e n ti ns e v e r a lc e l l
types. This increase in SOD level is expected to result in
increased generation of hydrogen peroxide which can in turn
aﬀect the expression of many redox-sensitive genes (such
as MMP-1 and MMP-2 codifying for extracellular matrix-
degrading metalloproteinases [59]) and consequently a dis-
placed equilibrium in the steady-state levels of ROS. This
process is associated with massive macrophage apoptosis and
contributes thereby to the formation of the atherosclerotic
lesions. The process may be further enhanced by cytokines
and other factors such as TNF, interleukin-1β, angiotensin
II, and interferon-γ [60–63].
3.Biochemical AlterationsandOxidative
DamageInducedby ROS
Therefore, currently, it is generally accepted that free radicals
or ROS play a primary role in the aging process, especially
in those tissues in which the generation of free radicals
is more pronounced, such as skeletal muscle. This is a
consequence of the high level of oxygen consumption,
seen in skeletal muscle compared to other tissues, which
results in higher concentrations of ROS [24], which are
not only involved in muscle damage but are also able to
modulate the contractile function of skeletal muscle [39].
Studies of reduced preparations have identiﬁed a number of
regulatory sites that exhibit altered function when exposed
to exogenous ROS donors ex vivo. There are insights haveOxidative Medicine and Cellular Longevity 5
correlated oxidative damage to the mechanisms underlying
EC (excitation-contraction) coupling. Since Ca2+ release
channels are one of the major targets of oxidative damage
[64, 65], the unbalance of Ca2+ transport that is present in
the sarcopenic muscle could be due to the modiﬁed oxidative
status of those structures involved in Ca2+ release and uptake
[66]. Several studies have shown the presence of an enzyme,
NAD(P)H-oxidase, that is associated with skeletal muscle SR
(sarcoplasmic reticulum) [67]. In fact, the superoxide anion
generated by this enzyme can stimulate the proper release
of calcium from SR through oxidation of the Ryanodine
receptor [67]. Ryanodine receptor 1 (RyR1) is the calcium
release channel of the skeletal muscle SR required for muscle
contraction. Related experiments showed as RyR1 from
aged (24-month-old) rodents resulted oxidized and cysteine-
nitrosylated compared to RyR1 from younger (3–6-month-
old) adults. RyR1 channel activity is dramatically altered
by redox modiﬁcations of critical thiols group contained
in the protein (oxidation, S-nitrosylation, or alkylation); an
oxidationofapproximately20%ofthesefreethiolsisenough
to produce a signiﬁcant eﬀect on the channel activity that
in some case can lead to an irreversible inactivation of the
channel. These data indicate that leaky RyR1 contributes to
age-related loss of muscle function [68, 69].
The involvement of other enzymes, such as Phospholi-
pase A2 (PLA2) and xanthine oxidase, has been suggested.
The activation of PLA2 may stimulate NAD(P)H oxidase,
while it has been shown that increases in PLA2 activity stim-
ulate ROS production in mitochondria and in cytosol, and
subsequent release in extracellular space [70]. PLA2 enzyme
is present in cells as two isoforms: calcium-dependent
PLA2 (cPLA2) and non-calcium-dependent PLA2 (iPLA2).
It has been suggested that iPLA2 is mostly responsible for
ROS production at rest, while isoform cPLA2 seems to
be activated during all processes that increase intracellular
Ca-concentration, such as muscle contraction [70]. Xan-
thine dehydrogenase (XDH) is a cytoplasmic enzyme that
is converted to Xanthine oxidase, which in turn is able
to produce superoxide anion and, accordingly, hydrogen
peroxide. Skeletal muscle generates superoxide and nitric
oxide at rest, and this generation is increased by contractile
activity. Proteins, such as superoxide dismutases (SODs),
catalase (CAT), and heat shock proteins (HSPs), prevent
oxidative damage to tissues.
The mechanisms underlying these adaptive responses
to contraction include activation of redox-sensitive tran-
scription factors, such as nuclear factor-kappaB (NF-κ B),
activator protein-1 (AP-1), and heat shock factor 1 (HSF1)
[1]. Moreover the literature reports that postcontraction
attenuation of the pathways involved in mitochondrial
biogenesis in fast muscle ﬁbers (type II) is far more severe
in old rats than in those of young rats. ROS are known to
playanimportantroleintheactivationofsignallingcascades
[71]. These latter suggest that ROS aﬀect mitochondrial
biogenesis via upregulation of transcriptional regulators,
such as peroxisome proliferator-activated receptor-gamma
coactivator-1 protein-alpha (PGC-1alpha) and that exces-
sively high ROS generation subsequent to contractions may
be responsible for diminished mitochondrial biogenesis in
the muscles of old rats. The inability of skeletal muscle from
old rats to activate redox-sensitive transcription factors such
as NF-κ Bo rA P - 1i nr e s p o n s et os t r e s si sc h a r a c t e r i z e d
by chronic activation of transcription factors at rest and
by an inability to further activate these factors subsequent
to muscle contraction. This lack of activation of redox-
sensitive transcription factors with contractile activity is
associated with an inability to increase the expression of
various cytoprotective proteins and appears to inﬂuence the
susceptibilityofskeletalmusclefromoldanimalstooxidative
damage [72, 73].
3.1. Lipid Damage. One of the principal indicators of
free radical damage during aging is lipid peroxide (LPO).
Polyunsaturated fatty acids (PUFAs) of the biomembranes
are attacked by free radicals in presence of the oxygen; mal-
ondialdeyde (MDA) and 4-hydroxy-2,3-trans-nonenal (4-
HNE) are the main products of PUFA peroxidation because
they bear numerous double bonds such as linoleic acid and
arachidonic acid. The main eﬀect on lipid peroxidation of
biological membranes is the overall decrease in their ﬂuidity,
which makes it extremely easy for the two monolayers to
exchange phospholipids, increases the permeability of the
membrane to substances that are not normally able to cross
other than by speciﬁc channels, and ultimately results in
severe damage to membrane proteins. These latter tend to
aggregate and to form high-molecular-weight complex [74].
In human skeletal muscle, LPO levels are signiﬁcantly
higher in aged than in young subjects [75]. There are
works that have demonstrated that there is an age-dependent
increase in MDA content in skeletal muscle [76, 77], and
also data obtained from our research group in these years
agree with those reported by previous authors. Furthermore,
LPO levels in young women are signiﬁcantly lower (by about
5 0 % )t h a ni ny o u n gm e n[ 36, 75]. Possibly, the diﬀerence
in lipid peroxidation between young and aged women could
be caused by the reduction of estrogens’ protective role after
menopause. In any case, the level reached in elderly women
islowercomparedtomen[31,75];inparticular,MDAvalues
in the VL (vastus lateralis) muscle in aged females (over 70)
werecomparabletothoseobtainedfromyoungmales(under
40) [77].
In human skeletal muscle, the level of peroxidation
also depends on muscle ﬁber composition and on muscle
function. Fiber composition indicates that muscle with more
than 40% type II ﬁber content shows statistically lower LPO
levels than does muscle with less than 40% type II ﬁber
content [75]. This suggests that increased lipid peroxidation
prevails in type I ﬁbers (which are mainly oxidative), where
most ROS production probably takes place by mitochondrial
alteration [1]. An increase in the LPO level during aging is
evident in the VL [75, 77, 78] and in the external intercostal
[75], but not in the RA (rectus abdominis)m u s c l e[ 77]. Fiber
I distribution is very similar in RA and VL, which suggests
that functional diﬀerences in these muscles could be the
cause of major lipid peroxidation. There are two possible
explanations for the observation that oxidative lipid levels in
RA diﬀer from those in VL: the greater contractile capacity6 Oxidative Medicine and Cellular Longevity
of VL muscle compared with RA muscle and/or the higher
levels of peroxidable substrates present in VL compared
with RA. On the base of these results, it seems that lipid
peroxidation level are inﬂuenced by a variety of diﬀerent
factors: sex, ﬁber composition, and muscle speciﬁcity [1].
4. ProteinCarbonylation
A great number of studies have shown an increase in oxi-
dized proteins at the intracellular level during senescence.
For the most part, oxidative-modiﬁed proteins are not
repaired and must be removed by proteolytic degradation
carried out by proteosome, which selectively degrades
damaged proteins [15]. The molecular mechanism that
causes the accumulation of oxidative-modiﬁed proteins is
not completely clariﬁed. Nevertheless, the oxidative damage
to proteins has several physiological implications related to
the loss of function in the aﬀected proteins with deducible
consequences for the organism. Protein oxidative damage
involves both the loss of thiol groups, and modiﬁcations
to amino acids that constitute the polypeptide chain, in
particular, histidine. Protein carbonylation (PC) is used as
a marker of oxidative damage, which acts, in particular, on
the side chains of the amminoacid residues lysine, arginine,
proline, and threonin; this may occur either directly or
indirectly as a consequence of lipid peroxidation [79].
Since oxidized protein is harmful to the maintenance of
cellular homeostasis, it requires rapid removal by proteolytic
digestion. PC content increases drastically in the last third
of the life span [80] and reaches a level such that on
average one out of every three protein molecules carries
modiﬁcation. Both in men and in women, PC content tends
to increase during aging, but in women these changes are
not statistically signiﬁcant [31]. Increasing amounts of PC
content were observed and compared during aging in male
skeletal muscles, but only in subjects younger than age 40
and older than age 70 [31]. Muscles with diﬀerent functions
in humans have been compared [77], and some authors
reported an increase in PC level during aging in both the
VL [81] and the external intercostal [78]; in other cases, the
increase was not statistically signiﬁcant in the VL [77, 78]
and in the RA [77]. The diﬃculty in showing signiﬁcant
changes in PC in the chronic physiological process could be
due to the dynamic features of the process: during aging,
myoﬁbrillar carbonyl content has been shown to increase
signiﬁcantly three hours after acute oxidative stress, only
to return to its basic level within a few hours, in contrast
withthenormalconditioninskeletalmuscleascharacterized
by a relatively slow protein turnover [82]. Finally, protein
carbonyl content tend to increase during aging and although
data recently obtained from our research do not reach
statistical signiﬁcance, they are in line with those obtained in
otherstudiesonthebrain,heart,andkidney[83]andsk eletal
muscle [84].
5. MitochondrialDNA Damage
Mitochondrial DNA (mtDNA) is a double-stranded ring
(about 16.5kb) encoding 13 subunits of the ETC (electron
transport chain) as well as 2rRNA and 22tRNA protein
necessary for their translocation. Mitochondrial DNA lacks
introns and is devoid of histones and other DNA-associated
proteins; it is located in mitochondrial matrix, close to the
major source of ROS [15]. For all these reasons, the prob-
ability of the oxidative modiﬁcation of a coding region of
mtDNAisveryhigh.Moreover,therepairdevicesofmtDNA,
even present, are largely insuﬃcient to overcome extensive
DNA damage which, furthermore, persist longer than that
nuclear DNA, as demonstrated by in vitro experiments with
cell cultures [85, 86].
The high turnover of mitochondria and the not suﬃcient
mtDNArepair systemscannotcounteracttheoxidative dam-
age that accumulates. This involves a progressive accumula-
tion of mitochondrial functional impairment and, therefore,
a lower availability of energy and consequent impairment of
cell functions. Therefore, ROS can damage DNA either by
an indirect mechanism, or by direct interaction with several
molecules.Indirectmechanisminvolvestheperoxides,which
can oxidize-SH groups of Ca2+ channels in the endoplasmic
reticulum, which contains ion cell, and thus determines its
release [87]. Increases in intracellular calcium can stimulate
Ca2+-dependent endonucleases and it can results in excessive
and incorrect DNA fragmentations. The hydroxyl radical
bears the greatest responsibility for the damage caused by
ROS with a direct mechanism. HO
• reacts indiscriminately
with both sugars, ribose and deoxyribose, and with both
nucleobases, purine and pyrimidine, by addition and H-
abstraction. In this case, modiﬁed bases induce DNA strand
breakage, during replication, and pairing errors with con-
sequent mutations [88]. HO
• reacts predominantly with
Guanine in C8 and C4 of the ring, thus generating Guanine
radical. In the presence of oxygen or other oxidizing agents,
theGuanineradicalisconvertedtostableproduct8-hydroxy-
2 -deoxyguanosine (8-OHdG) [89] ,w h i c hi sc o n s i d e r e da
good biomarker of oxidative DNA damage [90].
Data obtained in male skeletal muscle indicate an
increase in DNA damage during aging [32, 81]f o rp o o l e d
male and female data [37]. In fact, investigations of human
skeletal muscle have established a correlation between age
and the accumulation of mtDNA deletions an mutations
[91]. It has also been suggested that mtDNA mutations
start to occur after the fourth decade of life, and that they
accumulate with age in postmitotic tissues [92]. There is
strong evidence for continuous age-related increase in the
levels of oxidative stress and oxidative damage on mitochon-
drial biomolecules, damage that becomes progressively more
apparent with advancing age [93]. However, progressive loss
of mitochondrial redundancy may not limit human skeletal
muscle’s capacity to supply the cellular energetic demands at
basal metabolic conditions. This is important, because such
limits might constrain the functioning of myoﬁbers during
situations with higher energy requirements. Moreover, an
increase in MDA content is signiﬁcantly correlated with
an increase in 8-OHdG, a ﬁnding which suggests a direct
correlation between lipid peroxidation and DNA damage in
human skeletal muscles [37]. It has been demonstrated that
deletion patterns of mtDNA over a lifetime are tissue speciﬁc
and more pronounced in the skeletal muscle and heart [94].Oxidative Medicine and Cellular Longevity 7
It is also important to note that in human skeletal
muscle oxidative damage is probably lower in aged women
compared with aged men [32]. In particular, it seems that
women are more protected against molecular oxidative stress
during premenopausal life period suggesting a signiﬁcative
antioxidant role of estrogen, present in high levels in women.
These hormones could contribute, therefore, to enhancing
antioxidant defences in female muscles [95]. During the fer-
tile age, these hormones probably induce a less accumulation
of the oxidative damage with respect to males, determining a
more favourable condition in the aging process [15].
5.1. The Antioxidant Defence in Aged Muscle. Antioxidants
are substances able to inhibit the rate of oxidation [96,
97]. Biological antioxidant elements are present under
diverse and numerous forms and they can be categorized
as enzymatic (superoxide dismutase (SOD), catalase (CAT),
glutathione peroxidase (GPx), glutathione reductase (GR))
and nonenzymatic (ascorbate, tocopherol, beta-carotene,
reducedcoenzymeQ,orubiquinol,reducedglutathione,uric
acid,andmineralslikeseleniumandzinc).Theseantioxidant
systems act as primary intracellular defences against reactive
oxygen species before their interaction with macromolecules
protecting cells from free radical damage. Nevertheless,
since free radicals are necessary for correct functioning
of human organism, eﬃcient mechanisms of enzymatic
antioxidant defence had to be developed, especially in cells
highly exposed to oxidation processes like those of skeletal
muscle with the aim of protecting cellular constituents. The
equilibrium between ROS production and the antioxidant
defences at the level of the cellular structures determines
whether a cell exposed to ROS increase will survive or will be
seriously damaged or will die inducing apoptosis [98]. The
enzymatic antioxidants serve mainly intracellularly, being
absent or present in small amounts extracellularly, and they
prevent free radical chain propagation by interrupting initi-
ation. This is particularly important in the intravascular and
connective-tissue spaces [99]. Nonenzymatic antioxidants
can be divided into lipid- and water-soluble molecules.
Among the nonenzymatic antioxidant molecules, the most
important and studied are the vitamins C and E.
5.2. Non-Enzymatic Antioxidants. Endogenous non-enzy-
matic elements with antioxidant properties contribute to
the maintenance of homeostasis by primarily acting as
cofactors for the antioxidant enzymes. A major source of
antioxidants is diet [100]. Among dietary antioxidants, the
most important (and also largely available as supplements)
are vitamin C, vitamin E, and carotenoids. Tocopherol
(vitamin E) and beta-carotene, a precursor of vitamin A,
are the main lipid-soluble nonenzymatic antioxidants. They
are mainly localized to cell membranes and LDL. Alpha-
tocopherol, the most active form of vitamin E, breaks
free radical chain reactions. Given its location, tocopherol
inhibits already initiated lipid peroxidation, in addition
to having several other antioxidant eﬀects. Beta-carotene
interacts primarily with singlet oxygen by “de-exciting” it.
Moreoverithasbeenreportedasigniﬁcantlyhighcorrelation
ofα-tocopherol(themostdiﬀuseformofcirculatingvitamin
E) with physical performance, and of γ-tocopherol with
skeletal muscle strength [101].
Ascorbate (AA) is the main water-soluble nonenzymatic
antioxidant. AA interacts with a wide variety of free radicals
intracellularly and forms a front-line extracellular defence
against free radicals in plasma [102]. AA is moreover able
to interact with superoxide and hydroxyl-free radicals, in
addition to singlet oxygen. Ascorbate free radical, with
its relatively low redox potential, does not propagate free
radical chain reaction [103, 104]. One additional important
antioxidant role ascorbate plays is in the regeneration of
alpha-tocopherol (the most active form of vitamin E) from
the tocopherol radical [105, 106]. Thus, AA does not only
directly protect membranes and LDL from ROS generated
in the aqueous phase but also indirectly protects them by
reduction of vitamin E radical. Moreover, ascorbic acid
concentrations are inversely associated with isoprostanes, a
marker of lipid peroxidation [107] and it has a number
of well-deﬁned biological functions, including collagen,
catecholamine, and carnitine biosynthesis [101–103].
Recent investigations are emerging that show that low
serum/plasma carotenoids are independently associated with
poor skeletal muscle strength and impaired physical perfor-
mance. Among 669 women aged 70–79 years in the Women’s
Health and Aging Studies (WHAS) I and II, low serum
carotenoid levels were associated with poor muscle strength
[108]. Also, other studies showed carotenoids provide a
balance to reactive oxygen species [109].
The diet is, moreover, a very important source of
carotenoid. The six major dietary carotenoids, up-taken
mostly from fruits and vegetables (α-carotene, β-carotene,
β-cryptoxanthin, lutein, zeaxanthin, and lycopene) comprise
an important component of the antioxidant defense system
in humans protecting against oxidative stress by quenching
singlet oxygen, scavenging free radicals, inhibiting lipid
peroxidation, and modulating redox-sensitive transcription
factors that are involved in the upregulation of proinﬂam-
matory cytokines [103, 107]. Carotenoids are hydrophobic
molecules, and thus, interact with lipophilic elements of the
cell, such as the lipid membrane bilayer. They are commonly
located within cell membranes, and the location of speciﬁc
carotenoids within the membrane structure depends upon
the chemical structure of the carotenoid [109].
Other important and powerful nonenzymatic antiox-
idant is glutathione (GSH/GSSG). It is representing also
the base material for several other important antioxidant
enzymes including glutathione-peroxidase, glutathione-
reductase, and glutathione-transferase. Glutathione is a
compound classiﬁed as a peptide made of three amino
acids:cysteine,glutamicacid,andglycine.Glutathioneisalso
found in every part of the body, especially the lungs, intesti-
nal tract, and liver. The body produces and stores the largest
amounts of GSH in the liver, where it is used to detoxify
harmful compounds so that they can be removed from the
body through the bile. The liver also supplies GSH directly to
red and white blood cells in the bloodstream; it helps keep
red blood and white blood cells healthy to maximize the
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also appears to have an anti-aging aﬀect on the body. Strong
evidence that glutathione depletion causes cell death comes
fromcellculturestudiesbyLiandcolleague[110].Alsoother
works showed that direct depletion of mitochondrial and
cytoplasmic GSH resulted in increased generation of ROS,
disruption of the mitochondrial transmembrane potential,
and rapid loss of mitochondrial function [111, 112].
The CoQ10 (Q10 coenzyme) is also an important
endogenous compound in preserving mitochondrial func-
tion and it cooperates in maintaining a proper energy level,
which serves to prevent the aging skin from switching to
anaerobic energy production mechanisms. Furthermore, the
antioxidantcapacityofCoQ10contributestoapositiveeﬀect
against UV-mediated oxidative stress [103].
5.3. Enzymatic Antioxidants. Probably the main physiolog-
ical mechanism by which cells regulate ROS activities (and
thus protect against oxidative damage) consists, ﬁrstly, in
modiﬁcationoftheexpressionandactivitiesoftheregulatory
enzymes such as SOD, CAT, GPx, haem oxygenase-1 (HO-1)
and, secondly, in increases in other cytoprotective proteins,
suchasHSPs[29].Theseenzymesworktomaintainastateof
balancepreventingthetransformationofROSandtoconvert
them into more stable molecules (like water and molecular
oxygen). There is a great controversy in the literature as
to whether or not aging is associated with an increase or
decrease of enzymatic antioxidant defence in the cell. Results
reported in the literature need to be carefully interpreted
taking into account sex, muscle ﬁber composition, and
speciﬁcity [15].
5.4.SuperoxideDismutase(SOD). SODisoneoftheprimary
enzymatic antioxidant defences, and it readily converts
superoxide radicals (O2−) in hydrogen peroxyde (H2O2). An
increase in total SOD activity corresponds with enhanced
resistance to oxidative stress [113]. SOD exists in two
forms,cytosolic(Cu-ZnSOD)andmitochondrial (MnSOD).
MnSOD activity in skeletal muscle, both in rats [114] and in
men [2, 114, 115], is reported to increase signiﬁcantly with
aging and to respond to age-related oxidative stress on the
mitochondria by upregulation [15]. In human, moreover,
as in the rats, the age-dependent enhancement in MnSOD
activity is particularly evident in the RA [77] and in external
intercostal muscle [78] rather than in VL [75, 77, 82], sug-
gesting a marked increase in ROS production mainly in the
oxidative muscle respect to glycolytic muscle. Furthermore,
MnSOD activity value is comparable between young men
and women, doubling during aging in both sexes [31]. The
enzymatic level seems to play an active role in both women
and men during aging [15]. This regulatory mechanism,
therefore,partiallycounteractstheincreaseoffreeradicals,in
particularO2−,inthemitochondriainsenescenttissues.This
reinforces the hypothesis that mitochondrial stress, due to
an increased leakage in ETC during aging, is associated with
productionofsuperoxide.Accordingly,cytoplasmicSODdid
not show any change or decrease in activity during aging
[2, 32, 75].
In human skeletal muscle, the relationship between SOD
activity, aging, and sex was investigated [2], and the obtained
results showed that enzymatic activity in this kind of muscle
tissue in young women is about four-to-ﬁve times higher
than in men of the same age, suggesting that total SOD
activity could be a limiting factor in muscle defence against
oxidative damage in humans [15, 116]. Moreover, total SOD
activity appears to be signiﬁcantly higher in enriched type II
ﬁber muscle [31]. Strength training, which results in muscle
hypertrophy and improved muscular strength and power
[117, 118], could be an important factor in delaying the
progressive loss of type II ﬁbers in elderly subjects as well
[118, 119].
5.5. Catalase (CAT) and Glutathione Peroxidase (GPx). The
decomposition of hydrogen peroxide to form water and
oxygen is carried out in the cell by GPx and CAT. H2O2 has
the ability to freely cross the membrane and has relatively
long half life [120]. Like SOD, GPx and CAT are located
in both mitochondria and cytosol, where they provide
important cellular protection against free radical damage
to membrane lipids, protein, and nucleic acids [15]. Most
of the data on rats report an increase in CAT activity
both in senescent oxidative muscles and glycolytic muscles
[121]. This ﬁnding is consistent with the possibility that
nonmitochondrial ROS production increases. In contrast,
few and contradictory data are available on human skeletal
muscle. Some authors report no change in CAT activity
in men during aging [116]. No diﬀerences are observed in
CAT activity with aging in all condition tested: between
men and women, between muscles with diﬀerent ﬁber
compositions, and between oxidative and glycolytic muscles
[75], while other studies describe a signiﬁcant increase [76]
ordecreaseinCATactivityintheVL[32].Nevertheless,these
contradictory data could be due to the dynamics of CAT
activity during aging: in men, as in rats, a two-phase trend
was described: an initial decrease in adult animal followed by
a signiﬁcant enhancement in aged animals [114, 122].
In human skeletal muscles, GPx does not change during
aging, whether in glycolytic or oxidative muscle [123]. In
young rats, skeletal muscle ﬁbers with greater oxidative
capacity (like the soleus muscle) have higher levels of GSH
(reduced glutathione), the substrate for GPx to detoxify
hydrogen peroxide, and total glutathione content than those
with lower oxidative potential. In addition, one study reports
that GPx activity was higher in oxidative muscles and
thus caused less vulnerability and more resistance to an
exercise-induced oxidative stress, while the modest levels of
GSH and GPx in the deep or superﬁcial VL muscle were
associated with greater lipid peroxidation under exercise
stress [15]. Probably, GSH and GSSG (oxidized glutathione)
muscle levels, as well as the GSH/GSSG ratio, are closely
correlated with diﬀering muscle functions. Moreover, since
some data showed that in type I ﬁbers of both glycolytic and
oxidativemuscleinagingtheGSHandGSSGlevelsremained
unchanged [75], there is suggested that during aging there
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that there is ﬁber-speciﬁc adaptation of the GSH system in
the skeletal muscle [123].
5.6. Role of Nutrition against Muscle Oxidative Damage.
The beneﬁcial eﬀects of nutrition on the prevention of
oxidative stress have been attributed to the presence of
antioxidants contained mainly in vegetables: carotenoids,
plant polyphenols, tocopherols, ascorbate, phytic acid, and
selenium [1]. Recent epidemiological studies suggest that
carotenoids or carotenoid-rich foods are protective against
a decline in muscle strength and walking disability among
older community-dwelling adults. As report above, the
carotenoids protect against oxidative stress by quenching
singlet oxygen, scavenging free radicals, and inhibiting lipid
peroxidation [109]. The literature provides little evidence
of the possible eﬀects of antioxidant supplementation on
skeletal muscle aging [124–126]. On an animal aged model,
it has been showed that vitamin E and C supplementation
as well as a blend of polyphenols and carotenoids for 10
monthsresultedinsigniﬁcantlyincreasedactivityoftheGSH
system in muscle cell [125]; another study indicated that
mixed supplementation with rutin, vitamin E, vitamin A,
Zinc, and selenium restores the ability to stimulate protein
synthesis subsequent to leucine administration [124]; some
authors showed that vitamin C and E supplementation
attenuated the increase in markers of oxidative stress (H2O2,
MDA,and8-OHdG)inresponsetochronicrepetitivemuscle
loading, with an improvement in the work output of aged
muscles [125]. Altogether, the above studies suggest that a
diet supplemented with a combination of antioxidants may
possibly increase antioxidant defences, lower muscle oxida-
tive damage, and improve muscle protein balance during
senescence [1]. But if, overall, results consistently report
signiﬁcant improvements of antioxidant biomarkers after a
period of speciﬁc supplementation, diﬀerently, the eﬀect of
antioxidant supplementation on muscle performance is still
and largely controversial. In fact it is necessary to underline
that there are currently no trials verifying the eﬀects of
antioxidant supplementation on sarcopenia (as identiﬁed by
one of several the consensus deﬁnitions provided by inter-
national groups of experts). Interestingly, a recent statement
fromthesociety onsarcopenia,cachexia,andwastingdisease
does not even mention antioxidant supplementation as a
possible tool to manage sarcopenia in older persons [127].
On the other hand, in order to explain these controversial
ﬁndings, we must consider that the modiﬁcation of a
biomarker concentrations not automatically changes clinical
parameters. It is more likely that subclinical eﬀects are more
sensible to changes than clinically evident manifestations.
6. Conclusions
During organism aging, production of reactive oxygen
species is increased as a result of the functional deterioration
of mitochondria. There is strong evidence that increased
free radical generation may be the underlying reason for
several age-related pathogeneses. However, few studies have
actually measured aging-induced free radicals in human
skeletal muscles. It has been suggested that age-related oxi
dative stress may be a function of a reduction in enzymatic
antioxidant capacity, but this has not been demonstrated in
human skeletal muscle.
The increased production of free radicals with aging
plays a major role in targeting adaptive responses in
humanskeletalmuscle.Theadaptivemechanismsinvolvethe
antioxidant scavenger system and appear to be sex-, ﬁber-,
andmuscle-speciﬁc.Furthermore,theamountofintroduced
dietary antioxidants could play a speciﬁc and important
role even if further trials in humans are required to clearly
establish the hypothesized relationship between antioxidant
and sarcopenia [15].
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